Mobile Cardiac Telemetry Systems Market - By Product Type (Lead-based, Patch-based), Indication (Angina Pectoris, Coronary Artery Disease, Atherosclerosis, Stroke), End-use (Hospitals, Specialty Clinics, Diagnostic Centers) – Global Forecast (2024 – 2032)

Mobile Cardiac Telemetry Systems Market Size

Mobile cardiac telemetry systems market size was valued at around USD 1.1 billion in 2023 and is estimated to grow at 12.1% CAGR from 2024 to 2032. Mobile cardiac telemetry (MCT) systems are advanced medical devices designed for continuous monitoring of a patient's cardiac activity outside of a clinical setting. These systems typically consist of wearable sensors, adhesive electrodes, and a portable recording device that collects and transmits real-time electrocardiographic (ECG) data to a remote monitoring center or healthcare provider.

The growing aging population base is a significant driver for the mobile cardiac telemetry systems market. For instance, according to the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As individuals age, they become more susceptible to various cardiovascular conditions, such as coronary artery disease, arrhythmias, and heart failure. The aging process can lead to structural and functional changes in the heart and blood vessels, increasing the risk of cardiac events.
 

Furthermore, increasing shift towards home healthcare, rising adoption of cardiology information system (market size is estimated to account for USD 2.4 billion by the end of year 2032), advancement in cardiovascular ultrasound systems, increasing utilization of cardiovascular health supplements, government initiatives and funding, and increasing education & awareness, are the promoting factors fostering the growth of the market.
 

Mobile Cardiac Telemetry Systems Market Trends

The increasing incidence of cardiac disorders is a significant driver for market. Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality worldwide, affecting millions of individuals each year.
 

• For instance, according to the World Health Organization (WHO), in 2023, cardiovascular diseases (CVDs) are the leading cause of death globally taking an estimated 17.9 million lives each year.
• Similarly, as per World Heart Federation in 2023, deaths from cardiovascular disease (CVD) jumped globally from 12.1 million in 1990 to 20.5 million in 2021.
   
• MCT systems offer continuous real-time monitoring of cardiac activity over an extended period enabling the detection of transient arrhythmias, ischemic changes, and other abnormalities that may go unnoticed with intermittent monitoring approaches. Further, continuous monitoring with these systems allows for early detection of cardiac events and stroke management, facilitating timely intervention and reducing the risk of complications.
   
• Modern MCT devices are compact, lightweight, and discreet, allowing patients to wear them comfortably for extended periods without interference with their daily activities. These advancements have expanded the applicability of MCT systems across a wide range of patient populations, including those with complex cardiac conditions or high-risk profiles, thereby increasing the growth of the market.
   

Mobile Cardiac Telemetry Systems Market Analysis

Based on product type, the market is bifurcated into lead-based and patch-based. The lead-based segment is estimated to account for USD 1.9 billion by the end of 2032.
 

• Lead-based MCT systems are widely accepted in clinical practice and have been extensively studied and validated in various patient populations. Clinicians prefer these systems for their proven accuracy, reliability, and effectiveness in detecting cardiac abnormalities, including arrhythmias and ischemic events.
   
• These systems typically employ multiple leads attached to the patient's chest to capture cardiac activity from different angles and perspectives. This multi-lead configuration allows for comprehensive monitoring of the heart's electrical activity, enhancing diagnostic precision and the detection of subtle abnormalities.
   
• Additionally, lead-based systems typically employ standard adhesive electrodes that stick to the patient's skin, making it simple and dependable to attach them without the need for specialized equipment or training. This compatibility with standard electrodes streamlines the setup procedure for healthcare providers and improves patient comfort throughout the monitoring process.
   
• They can be tailored to meet the specific monitoring needs of patients with diverse cardiovascular diseases, supporting personalized care and treatment planning. Also, the relatively lower upfront costs and maintenance requirements of lead-based systems make them an attractive option for healthcare providers seeking efficient cardiac monitoring solutions, thereby leading the segmental growth.

Based on indication, the mobile cardiac telemetry systems market is divided into angina pectoris, coronary artery disease, atherosclerosis, heart failure, stroke, and other indications. The angina pectoris segment accounted for USD 314.7 million in 2023.
 

• Angina pectoris is one of the leading causes of morbidity and mortality globally, thus there is a considerable patient population experiencing angina symptoms who could benefit from continuous cardiac monitoring.
   
• For instance, according to the National Library of Medicine, in 2024, the prevalence of angina pectoris in the world in ranged from about 2% to 7%. Similarly, as per the same report there were 2,806,500 cases of angina pectoris in China in 2023.
   
• Angina is an important indicator and a marker of increased cardiovascular risk. Continuous monitoring with MCT systems can help healthcare providers assess the frequency, severity, and triggers of angina episodes, allowing for risk stratification and personalized treatment interventions to prevent adverse cardiac events such as myocardial infarction or sudden cardiac death.
   
• Diagnosing angina can be challenging particularly in cases where symptoms are atypical or occur infrequently. Thus, MCT systems offer continuous ECG monitoring, enabling the capture of transient ischemic changes or arrhythmias associated with angina episodes that may be missed with traditional diagnostic approaches such as stress tests equipment or Holter ECG.
   
• Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on end-use, the mobile cardiac telemetry systems market is segmented into hospitals, specialty clinics, diagnostic centers, homecare settings, and other end-users. The hospitals segment held a market share of 47.7% in the year 2023.
 

• Hospitals often serve patients with complex cardiac conditions who require continuous monitoring and specialized care. MCT systems are particularly valuable in hospital settings for monitoring patients with acute cardiac events, post-surgical recovery, or those admitted to intensive care units (ICUs) where close cardiac monitoring is essential for timely intervention.
   
• These settings offer a wide range of diagnostic and therapeutic services for patients with cardiovascular diseases including cardiac catheterization, electrophysiology studies, and cardiac surgery. MCT systems complement these services by providing continuous cardiac monitoring before, during, and after procedures, facilitating comprehensive patient care and optimizing treatment outcomes.
   
• Hospitals utilize MCT systems for inpatient monitoring of cardiac patients admitted for various reasons such as chest pain, arrhythmias, heart failure exacerbation, or myocardial infarction. Continuous monitoring with MCT systems allows healthcare providers to assess the patient's cardiac status in real-time, detect changes or complications early, and adjust treatment accordingly.
   
• Moreover, hospitals typically have the infrastructure, resources, and expertise necessary to implement and support MCT systems effectively. This includes access to trained cardiac monitoring technicians, healthcare professionals specialized in cardiology, and support staff familiar with the use of MCT technology.

U.S. mobile cardiac telemetry systems market is anticipated to grow at CAGR of 11.7% during the analysis timeframe.
 

• The country has a high prevalence of cardiovascular diseases, including coronary artery disease, arrhythmias, heart failure, and hypertension. These conditions contribute to a significant patient population in need of continuous cardiac monitoring, driving demand for MCT systems.
   
• For instance, according to the Centers for Disease Control and Prevention (CDCP), in 2022, about 6.2 million adults in the U.S. have heart failure.
   

Germany mobile cardiac telemetry systems market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Germany is known for its advanced healthcare infrastructure, which includes modern hospitals, medical clinics, and research institutions.
   
• The country has a well-developed healthcare system that emphasizes quality care and patient outcomes, providing a conducive environment for the adoption and utilization of innovative medical technologies like MCT systems.
   

Japan mobile cardiac telemetry systems market is expected to grow significantly over the years.
 

• The country has one of the world's most rapidly aging populations, with a significant proportion of elderly individuals who are at higher risk of cardiovascular diseases. For instance, according to statistics, in 2023, more than 1 in 10 people in Japan are aged 80 or older. National data also shows 29.1% of the 125 million population is aged 65 or older.
   
• Further, continuous cardiac monitoring with MCT systems is particularly relevant in Japan, where there is a growing demand for innovative healthcare solutions to address the healthcare needs of an aging society.
   

UAE mobile cardiac telemetry systems market is anticipated to witness lucrative growth between 2024 – 2032.
 

• UAE places a strong emphasis on technological innovation and digital transformation across various sectors, including healthcare.
   
• The government has launched initiatives to promote innovation and research in healthcare technology, encouraging the adoption of advanced medical devices and solutions like MCT systems to enhance patient care and outcomes.
   

Mobile Cardiac Telemetry Systems Market Share

The mobile cardiac telemetry systems industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive cardiac solutions with improved efficiency and affordability. This includes advancements in design, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
 

Mobile Cardiac Telemetry Systems Market Companies

Some of the eminent market participants operating in the mobile cardiac telemetry systems industry include:

• ACS Diagnostics
• Baxter International Inc.
• BIOTRICITY INC.
• Boston Scientific Cardiac Diagnostics Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Medicomp Systems
• ScottCare Cardiovascular Solutions
• Telerhythmics LLC
• Zoll Medical Corporation
   

Mobile Cardiac Telemetry Systems Industry News:

• In April 2024, Biotricity Inc. launched a pilot program of Technology-as-a-Service (TaaS) revolutionizing the medical diagnostic and consumer healthcare field, with a major hospital network encompassing over 50 hospitals across multiple states. The pilot program will demonstrate the value of Biotricity’s cardiac monitoring solutions, setting the stage for a potential large-scale commercial rollout across the network. Thus, expanding the horizon of mobile cardiac telemetry and sales of the company.
   
• In September 2023, iRhythm Technologies, Inc. announced the launch of its next-generation Zio monitor and enhanced Zio long-term continuous monitoring (LTCM) service. It was the smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. Thus, it increased the portfolio in the field of MCT and generated revenues.
   

The mobile cardiac telemetry systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Lead-based
• Patch-based

Market, By Indication

• Angina pectoris
• Coronary artery disease
• Atherosclerosis
• Heart failure
• Stroke
• Other indications

Market, By End-use

• Hospitals
• Specialty clinics
• Diagnostic centers
• Homecare settings
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa